WHO calls for probe into more than 200 Russian attacks on health facilities in Ukraine

WHO calls for probe into more than 200 Russian attacks on health facilities in Ukraine


CHERNIHIV, UKRAINE – MAY 09: A healthcare professional searches for medicines and medical equipment in a destroyed hospital as Russian attacks continue in Chernihiv, Ukraine on May 09, 2022. Patients are treated in additional buildings as health services are disrupted due to the destroyed hospitals. (Photo by Abdullah Unver/Anadolu Agency via Getty Images)

Anadolu Agency | Anadolu Agency | Getty Images

The World Health Organization on Tuesday called for investigations into Russian attacks on health-care facilities and ambulances in Ukraine.

The global health agency has documented 226 attacks since Russia invaded its neighbor on Feb. 24, according to Dr. Hans Kluge, WHO regional director for Europe. At least 75 people died and 49 were injured in the attacks, he said. 

“These attacks are not justified and they are never OK. And they must be investigated,” Kluge said during a press briefing at the Ukraine Media Center in Kyiv. 

The WHO will contribute to any investigation that takes place in the future, Kluge added.

His remarks come on the 83rd day of Russia’s invasion, which has caused thousands of civilian deaths and injuries in Ukraine, including children. Unprovoked attacks on health-care facilities and ambulances have climbed as the war drags on.

The latest figure more than doubles the 100 attacks verified by the WHO over a month ago. 

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:

WHO representative in Ukraine, Dr. Jarno Habicht, said the health-care facilities and ambulances attacked had served a quarter of a million Ukrainians each month in 2021. 

“So that’s the impact of those attacks. And those attacks are continuing, which is unacceptable. There is no reason for that,” Habicht said.

He added that two-thirds of all attacks on health-care facilities worldwide in 2022 have taken place in Ukraine alone. 

Habicht said the WHO has taken steps to support Ukraine’s health system. He noted that the agency has delivered more than 500 metric tons of medical supplies to the hardest-hit areas of the country since February. 

More than 50% of the supplies, including medicines, ambulances and electric generators, will go toward trauma and injury care. The WHO also provides medical kits to treat those with chronic illnesses, and one kit can provide three months of treatment for thousands of people, according to Habicht. 

He added the WHO is “very glad” that some governments and partners are also delivering medical supplies to Ukraine. 

Kluge called the conditions of the health system in Ukraine both “heartbreaking and inspiring.” He condemned the “devastating” effect the Russian assault has had on people’s lives, but praised the health workers in Ukraine for their commitment to those in need.  

“I’d like to express my immense appreciation and admiration for the health workers of this country who have shown tremendous bravery and dedication since the war began,” Kluge said. “You have done the impossible. You stand firm and save lives.”



Source

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Health

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound

Cr | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Another potential competitor to blockbuster obesity treatments from Eli Lilly and Novo Nordisk just showed positive data – but this time, […]

Read More
FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says
Health

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says

The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals of some treatments, the agency’s Commissioner Marty Makary told CNBC on Friday.  The FDA in June announced a national priority voucher plan that aims to cut drug review times to one-to-two months for companies it says are […]

Read More
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Health

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

The Hers website arranged on a laptop in New York, US, on Wednesday, Feb. 12, 2025. Gabby Jones | Bloomberg | Getty Images Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk‘s patent on its branded drugs Ozempic and Wegovy is set to expire in January. “Canada is […]

Read More